Managing bronchiectasis

Practitioner

Volumn 250, Issue 1681, 2006, Pages 194-207

  Bradley, Judy ^a   Lavery, Katherine ^a   Rendall, Jackie ^b   Elborn, J Stuart ^b,c  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BRONCHIECTASIS; CONFERENCE PAPER; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HUMAN; PHYSIOTHERAPY;

ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; PHYSICAL THERAPY MODALITIES;

EID: 33646201390     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Pasteur MC, et al. An Investigation into Causative Factors in Patients with Bronchiectasis. Am J Respir Crit Care Med 2000;162:1277-84
2. Lavery K, Bradley JM, Elborn JS. Bronchiectasis: challenges in diagnosis and management. Int J Respir Care 2005;1:92-8
3. National Institute for Clinical Excellence. Chronic Obstructive Pulmonary Disease: Clinical Guideline 12, 2004 (Online). Available from: www.nice.org.uk
4. Sheehan RE, Wells AU, Copley SJ et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 2002;20:581-7
5. Roberts HR, Wells AU, Milne DG et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000;55:198-204
6. Wilson CB, Jones PW, O'Leary CJ et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998;12:820-4
7. Evans SA, Turner SM et al. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996;9:1601-4
8. Kelly MG, Murphy S, Elborn JS. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur J Intern Med 2003;14:488-92
9. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonisation with pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Ped Pulm 1997;23:330-5
10. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. The Cothrane Database of Systematic Reviews 2002, Issue 2. Art. No: CD001392. DOI:10.1002/14651858.CD001392
11. Scheinberg P, Shore E. A Pilot Study of safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005;127:1420-6
12. Barker AF, Couch L, Fiel SB, Gotfried MH et al. Am J Respir Crit Care Med 2000;162:481-5
13. Saiman L, Marshall BC, et al. Azithromycin in patients with cystic fibrosis chronically infected with pseudomonas aeruginosa: A randomised controlled trial. JAMA 2003;290:1749-56
14. O'Neill B et al. The current physiotherapy management of patients with Bronchiectasis: A UK survey. Int J Clin Pract 2002;56:34-5
15. Patterson JE et al. Airway clearance in bronchiectasis: A randomised crossover trial of active cycle of breathing techniques (ACBT) versus Acapella®. Respir 2005;72:239-42
16. Thompson CS et al. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax 2002;57:446-8
17. Valente AM et al. The effect of two techniques on the characteristics and transport of sputum in patients with bronchiectasis. A pilot study. Physio 2004;90:158-64
18. Pryor JA. Physical Therapy for Adults With Bronchiectasis. Clin Pulm Med 2004;11:201-9
19. Tsang KWT et al. Inhaled Fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998;158:723-7
20. O'Neill B, Bradley JM, Macmahon J, Elborn S. Subjective benefit of inhaled therapies in patients with bronchiectasis: a questionnaire study. Int J Clin Pract 2004;58:441-3
21. Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis. The Cochrane Database of Systematic Reviews 2001, Issue 1. Art No.: CD001289. DOI: 10.1002/14651858.CD001289
22. O'Donnell AE et al. Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase. rhDNase Study Group. Chest 1998;113:1329-34
23. Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (seven per cent) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med 2005;99:27-31
24. Royal College of Physicians. Domiciliary Oxygen Therapy Services. A Report of the Royal College of Physicians, 1999 (Online). Available on order at www.rcplondon.ac.uk
25. Clinical component for the home oxygen service in England and Wales (Draft) British Thoracic Society (BTS) Working Group on Home Oxygen Services. August 2005. www.brit-thoracic.org.uk accessed August 2005
26. Department of Health. Self Care - A real choice. 2005 (Online). Available at www.dh.gov.uk/assetRoot/04/10/08/92/04100892.pdf
27. Sharples ED et al. A randomised, controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic. Thorax 2002;57:661-6